296 related articles for article (PubMed ID: 34583709)
21. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
24. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
25. Aggressive CD4/CD8 Double-Negative Primary Cutaneous T-Cell Lymphoma With Dural Invasion: A Rare Presentation of Mycosis Fungoides?
Haghayeghi K; Robinson-Bostom L; Olszewski A; Jackson CL; Patel NR; Sewastianik T; Carrasco RD; Shanmugam V; Treaba DO
Am J Dermatopathol; 2021 Jan; 43(1):63-66. PubMed ID: 32675473
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
27. The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates.
Ashton-Key M; Diss TC; Du MQ; Kirkham N; Wotherspoon A; Isaacson PG
Am J Surg Pathol; 1997 Jul; 21(7):743-7. PubMed ID: 9236829
[TBL] [Abstract][Full Text] [Related]
28. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
29. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.
Kawana Y; Suga H; Kamijo H; Miyagaki T; Sugaya M; Sato S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830466
[TBL] [Abstract][Full Text] [Related]
30. Early-stage mycosis fungoides variants: case-based review.
Cho-Vega JH; Tschen JA; Duvic M; Vega F
Ann Diagn Pathol; 2010 Oct; 14(5):369-85. PubMed ID: 20850703
[TBL] [Abstract][Full Text] [Related]
31. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP
J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784
[TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern.
Hu SW; Ratech H; Naeem R; Latkowski JA; Kamino H
J Cutan Pathol; 2015 Oct; 42(10):730-8. PubMed ID: 26009972
[TBL] [Abstract][Full Text] [Related]
33. PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.
Liu F; Gao Y; Xu B; Xiong S; Yi S; Sun J; Chen Z; Liu X; Li Y; Lin Y; Wen Y; Qin Y; Yang S; Li H; Tejasvi T; Tsoi L; Tu P; Ren X; Wang Y
Blood; 2022 Jan; 139(4):554-571. PubMed ID: 34582557
[TBL] [Abstract][Full Text] [Related]
34. Oral involvement of cutaneous T-cell lymphoma: A rare entity.
Mahajan R; Davila A; Alawi F; Tanaka TI; Stoopler ET; Sollecito TP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 May; 135(5):e102-e107. PubMed ID: 36641326
[TBL] [Abstract][Full Text] [Related]
35. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
[TBL] [Abstract][Full Text] [Related]
37. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
[TBL] [Abstract][Full Text] [Related]
39. CD13 and TCR clone: markers of early mycosis fungoides.
Bernier C; Nguyen JM; Quéreux G; Renault JJ; Bureau B; Dreno B
Acta Derm Venereol; 2007; 87(2):155-9. PubMed ID: 17340024
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]